Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?
Özet
BACKGROUND: Seven dioxaborole compounds are investigated in this study. Structural and spectral
characterizations are done at the M062X/6-31+G(d,p) level in water. Active sites of these compounds are
determined by contour plots of frontier molecular orbital and molecular electrostatic potential (MEP) maps.
Electrophilic and nucleophilic attack regions are determined. Since SARS-CoV-2 is a worldwide health
problem, antiviral properties of studied boron-containing compounds are investigated by molecular docking
calculations. In addition to these calculations, MM/PSBA calculations are performed.
RESULTS AND CONCLUSION: It is found that the studied boron compounds can be good drug candidates
against the main protease of SARS-CoV-2, while the best of them is 4,6-di-tert-butyl-2-(4-methoxyphenyl)
benzo[d][1,3,2] dioxaborole (B2) (Tab. 3, Fig. 8, Ref. 23).